180 related articles for article (PubMed ID: 3018687)
1. Effector mechanisms of peptides of the VIP family.
Christophe J; Svoboda M; Lambert M; Waelbroeck M; Winand J; Dehaye JP; Vandermeers-Piret MC; Vandermeers A; Robberecht P
Peptides; 1986; 7 Suppl 1():101-7. PubMed ID: 3018687
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship.
Christophe J; Svoboda M; Waelbroeck M; Winand J; Robberecht P
Ann N Y Acad Sci; 1988; 527():238-56. PubMed ID: 2839079
[TBL] [Abstract][Full Text] [Related]
3. Effect of freezing on the coupling of VIP receptors to adenylate cyclase in rat liver membranes.
Robberecht P; Waelbroeck M; De Neef P; Camus JC; Gourlet P; Christophe J
Life Sci; 1988; 42(5):505-10. PubMed ID: 2828794
[TBL] [Abstract][Full Text] [Related]
4. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1986 Aug; 159(1):45-9. PubMed ID: 3017717
[TBL] [Abstract][Full Text] [Related]
5. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
6. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
7. Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes.
Robberecht P; Waelbroeck M; Camus JC; De Neef P; Christophe J
Biochim Biophys Acta; 1984 Jun; 773(2):271-8. PubMed ID: 6329286
[TBL] [Abstract][Full Text] [Related]
8. Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas.
Robberecht P; Waelbroeck M; Coy D; De Neef P; Camus JC; Christophe J
Peptides; 1986; 7 Suppl 1():53-9. PubMed ID: 3018703
[TBL] [Abstract][Full Text] [Related]
9. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
[TBL] [Abstract][Full Text] [Related]
10. Interaction of synthetic N- and C-terminal fragments of helodermin with rat liver VIP receptors.
Robberecht P; Yanaihara N; Yanaihara C; De Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J
Peptides; 1986; 7 Suppl 1():79-82. PubMed ID: 3018706
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
Rodríguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
12. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
[TBL] [Abstract][Full Text] [Related]
13. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
Juarranz MG; De Neef P; Robberecht P
Prostate; 1999 Sep; 41(1):1-6. PubMed ID: 10440869
[TBL] [Abstract][Full Text] [Related]
15. Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes.
Robberecht P; Waelbroeck M; de Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J
FEBS Lett; 1984 Jun; 172(1):55-8. PubMed ID: 6329822
[TBL] [Abstract][Full Text] [Related]
16. Iodinated derivatives of the vasoactive intestinal polypeptide (VIP) are agonists at the cat pancreas and the rat submandibular salivary gland.
Halldén G; Abens J; Engström C; Westlind A; Mutt V; Bartfai T
Regul Pept; 1986 Dec; 16(2):183-8. PubMed ID: 3027765
[TBL] [Abstract][Full Text] [Related]
17. G-protein regulation of adenylate cyclase activity in rat prostatic membranes after chronic ethanol ingestion.
Juarranz MG; Guijarro LG; Bodega G; Prieto JC
Prostate; 1998 Sep; 36(4):226-34. PubMed ID: 9719022
[TBL] [Abstract][Full Text] [Related]
18. Comparison of VIP-secretin receptors in rat and human lung.
Christophe J; Chatelain P; Taton G; Delhaye M; Waelbroeck M; Robberecht P
Peptides; 1981; 2 Suppl 2():253-8. PubMed ID: 6123988
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a guanosine-nucleotide-binding-protein-coupled receptor for pituitary adenylate-cyclase-activating polypeptide on plasma membranes from rat brain.
Schäfer H; Schwarzhoff R; Creutzfeldt W; Schmidt WE
Eur J Biochem; 1991 Dec; 202(3):951-8. PubMed ID: 1662620
[TBL] [Abstract][Full Text] [Related]
20. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
Koch BD; Schonbrunn A
Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
